COMPANY

Olympus Corporation

Articles that reconnect the numbers in this company’s primary sources into a clearer picture of the business.

Olympus CorporationFiscal year ended March 2026

The work behind an Olympus endoscope after delivery.

¥1.011tnYear ended March 2026 consolidated revenue
69%Gastrointestinal Solutions share
~90%Sales outside Japan (site calculation)
What emerges

Olympus supplies healthcare professionals with endoscopes and treatment devices, and provides installation checks, operating instruction, in-use support, inspection and repair. Medical Service represented about 30% of the GI division's ¥697.4bn revenue for the year ended March 2026. This is a divisional revenue share, not a group share or a measure of subscription revenue or profitability. Supporting equipment in use forms part of the medical business.

See the company through the numbers →